Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB04831ApprovedWithdrawnSmall molecule
Tienilic acid, or ticrynafen, is a diuretic drug with uric acid-lowering action which was marketed for the treatment of hypertension. It was withdrawn in 1982 after case reports in the...
- Primary indication
- For the treatment of hypertension.Curator reviewed
- Formula / weight
- C13H8Cl2O4S · 331.171 g/mol (avg)
- Also known as
- Thienylic acid · Ticrynafen
Resolves to
Clinical / RWD
Structure
InChIKey
AGHANLSBXUWXTB-UHFFFAOYSA-NSMILESOC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C1=CC=CS1What you can answer from here — as of March 06, 2025
Which companies are running trials of Tienilic acid, in which indications and phases, and which of those programs are still active?